True
False
True
False
True
False
True
False
True
False
True
False
Twice daily dosing
A high daily dose frequency
Once daily dosing
None of the above
Primary prevention of microvascular complications
Primary prevention of macrovascular complications
Secondary prevention of microvascular complications
Secondary prevention of macrovascular complicatIons
Treatment of symptomatic heart failure
Reduction of cardiac risk in patients with a history of myocardial infarction (MI) and/or coronary revascularisation
Treatment of essential hypertension
Treatment of unstable angina
93,6 % for perindopril
100,0 % for perindoprilat
98,2 % for perindopril
None of the above
True
False
True
False
20 mg/day
30 mg/day
60 mg/day
None of the above
Decreased in the group given nifedipine on awakening
Increased in the group given nifedipine on awakening
Increased in the group given nifedipine at bedtime
Decreased in the group given nifedipine at bedtime
13,4 % to 1,0 %
17,5 % to 4,0 %
13,5 % to 4,0 %
17,4 % to 1,0 %